Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing

Clinical Cancer Research

Volumn 3, Issue 5, 1997, Pages 741-747

  Cortazar, Patricia ^a   Gazdar, Adi F ^a   Woods, Edward ^b   Russell, Edward ^a   Steinberg, Seth M ^a   Williams, John ^b   Ihde, Daniel C ^a   Johnson, Brace E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SMALL CELL; CELL SURVIVAL; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030921383     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Salmon, S. E., Hamburger, A. W., Soehnlen, B., Durie, B. G. M., Alberts, D. S., and Moon, T. E. Quantitation of differential sensitivity of human tumor stem cells to anticancer. N. Engl. J. Med., 298: 1321-1327, 1978.
2. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47: 943-946, 1987.
3. Sondak, V. K., Korn, E. L., and Kern, D. H. In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay. Int. J. Cell Cloning, 6: 378-391, 1988.
4. Sanfilippo, O., Daidone, M. G., Costa, A., Canetta, R., and Silvestrini, R. Estimation of differential in vitro sensitivity of non-Hodgkin's lymphomas to anticancer drugs. Eur. J. Cancer, 17: 217-226, 1981.
5. Bogden, A. E., Griffin, W., Reich, S. D., Costanza, M. E., and Cobb, W. R. Predictive testing with the subrenal capsule assay. Cancer Treat. Rev., 11(Suppl. A): 113-124, 1984.
6. Poupon, M. F., Arvelo, F., Goguel, A. F., Bourgeois, Y., Jacrot, M., Hanaia, N., Arriagada, R., and Le Chevalier, T. Response of small cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J. Natl. Cancer Inst., 85: 2023-2029, 1993.
7. Yamaue H., Tanimura, H., Tsunoda, T., Tani, M., Iwahashi, M., Noguchi, K., Tamai, M., Hotta, T., and Arii, K. Chemosensitivity testing and highly purified fresh human tumor cells with the MTT colorimetric assay. Eur. J. Cancer, 27: 1258-1263, 1991.
8. Von Hoff, D. D., Sandbach, J. F., Clark, G. M., Turner, J. N., Forseth, B. F., Piccart, M. J., Colombo, N., and Muggia, F. M. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J. Natl. Cancer Inst., 82: 110-116, 1990.
9. Wilbur, D. W., Camacho, E. S., Hilliard, D. A., Dill, P. L., and Weisenthal, L. M. Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. Br. J. Cancer, 65: 27-32, 1992.
10. Gazdar, A. F., Steinberg, S. M., Russell, E. K., Linnoila, R. I., Oie, H. K., Ghosh, B. C., Cotelingam, J. D., Johnson, B. E., Minna, J. D., and Ihde, D. C. Correlation of in vitro drug-sensitivity testing with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J. Natl. Cancer Inst., 82: 117-124, 1990.
11. Ihde, D. C., Mulshine, J. L., Kramer, B. S., Steinberg, S. M., Linnoila, R. I., Gazdar, A. F., Edison, M., Phelps, R. M., Lesar, M., Phares, J. C., Grayson, J., Minna, J. D., and Johnson, B. E. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small cell lung cancer. J. Clin. Oncol., 12: 2022-2034, 1994.
12. Shaw, G. L., Gazdar, A. F., Phelps, R., Linnoila, R. I., Ihde, D. C., Johnson, B. E., Oie, H. K., Pass, H. I., Steinberg, S. M., Ghosh, B. C., Walsh, T. E., Nesbitt, J. C., Cotelingam, J. D., Minna, J. D., and Mulshine, J. L. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug-sensitivity testing. Cancer Res., 53: 5181-5187, 1993.
13. Weisenthal, L. M., Marsden, J. A., Dill, P. L., and Macaluso, D. K. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res., 43: 749-757, 1983.
14. Bosanquet, A. G., Bird, M. C., Price, W. J., and Gilby, E. D. An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. Br. J. Cancer, 47: 781-789, 1983.
15. Ihde, D. C. Drug therapy: chemotherapy of lung cancer. N. Engl. J. Med., 327: 1434-1441, 1992.
16. Organization, W. H. The World Health Organization histologic typing of lung tumors: second edition. Am. J. Clin. Pathol., 77: 123-136, 1982.
17. Johnson, B. E., Bridges, J. D., Sobczeck, M., Gray, J., Linnoila, R. I., Gazdar, A. F., Hankins, L., Steinberg, S. M., Edison, M., Frame, J. N., Pass, H., Nesbitt, J., Holden, D., Mulshine, J. L., Glatstein, E., and Ihde, D. C. Patients with limited-stage small cell lung cancer treated with concurrent twice daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J. Clin. Oncol., 14: 806-813, 1996.
18. Weisenthal, L. M., Dill, P. L., Kurnick, N. B., and Lippman, M. E. Comparison of dye exclusion assays with a clonogenic assay in determination of drug-induced cytotoxicity. Cancer Res., 43: 258-264, 1983.
19. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
20. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
21. Cox, D. R. Regression models and life tables. J. Royal Stat. Soc., 34: 187-220, 1972.
22. Vaaler, A. K., Forrester, J. M., Lesar, M., Edison, M., Venzon, D., and Johnson, B. E. Obstructive atelectasis in patients with small cell lung cancer, Chest, 111: 115-120, 1997.
23. Dombernowsky, P., and Hansen, H. H. Combination chemotherapy in the management of superior vena cava obstruction in small cell anaplastic carcinoma of the lung. Acta Med. Scand., 204: 513-516, 1978.
24. Würschmidt, F., Bünemann, H., and Heilmann, H. P. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int. J. Radiat. Oncol. Biol. Phys., 33: 77-82, 1995.
25. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Campbell, H., Mayo, J., and Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 83: 757-766, 1991.
26. Johnson, B. E. MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer. J. Cell. Biochem., 24(Suppl.): 210-217, 1996.
27. Eagan, R. T., Frytak, S., Nichols, W. C., Ingle, J. N., Creagan, E. T., and Kvols, L. K. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers. Cancer Treat. Rep., 65: 453-458, 1981.
28. Aisner, J., Whitacre, M., Van Echo, D. A., and Wiernik, P. H. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. Cancer Treat. Rep., 66: 221-230, 1982.
29. Greco, F. A., Richardson, R. L., Snell, J. D., Stroup, S. L., and Oldham, R. K. Small cell lung cancer. Complete remission and improved survival. Am. J. Med., 66: 625-630, 1979.
30. Klastersky, J., Nicaise, C., Longeval, E., and Stryckmans, P. Cisplatin, Adriamycin, and etoposide (CAV) for remission induction of small cell bronchogenic carcinoma. Cancer (Phila.), 50: 652-658, 1982.
31. King, G. A., Comis, R., Ginsberg, S., Goldberg, J., Dale, H. T., Brown, J., Dalal, P., Chung, C., and Gottlieb, A. Combination chemotherapy and radiotherapy in small cell carcinoma of the lung. Radiology, 125: 529-530, 1977.